DCOY
Decoy Therapeutics
$3.74
−$1.30 (−25.79%)Jul 27, 2026
Key metrics
The numbers that frame DCOY today
- Market cap
- $1.99M
- P/E (TTM)
- -0.2
- EV / FCF
- 0.9
- ROIC
- 476.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.72
- 52wk High
- $415.80
Growth
Revenue and earnings trend for DCOY
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DCOY
Is Decoy Therapeutics a good buy?
No. Decoy Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of DCOY?
Decoy Therapeutics's market capitalization is $1.99M.
What is the P/E ratio for DCOY stock?
Decoy Therapeutics's current P/E ratio is -0.2.
What is the 52-week high for DCOY stock?
The 52-week high for Decoy Therapeutics is $415.80. The current close of $3.74 is 99.1% below that high.
What is the 52-week low for DCOY stock?
The 52-week low for Decoy Therapeutics is $3.72. The current close of $3.74 is 0.5% above that low.
Does DCOY stock pay dividends?
Decoy Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DCOY?
Decoy Therapeutics's Debt / Equity ratio is 0.